More articles about: Colorectal Cancer

Kyle Kipke was diagnosed with rectal cancer and received chemotherapy and radiation as treatment at Michigan Medicine.

Andrew Sweeney, now 35, was aware of his risk for colorectal cancer – his mother had had been diagnosed with it when she was 41. When he was 31, a CT scan at University of Michigan Health’s University Hospital revealed that Sweeney had a mass in his colon and potential metastases in his liver and lymph nodes. A colonoscopy confirmed that he had stage 4 colorectal cancer. After 1.5 years of chemotherapy, his care team began discussing how they could remove the damaged parts of Sweeney’s liver. They developed a colorectal cancer liver transplant protocol from a deceased donor and Sweeney was the first patient to undergo a liver transplant in Michigan for colon cancer. After minor recurrences of tumors in his lung in 2024, which were treated by surgery and radiation, his scans have been clear.

Andrew Sweeney was diagnosed with stage 4 colorectal cancer at age 31 and underwent a liver transplant, chemotherapy and radiation treatment.

With colorectal (CRC) on the rise in younger patients, a specialist in gastroenterology and human genetics discusses why that may be and what to look for.

University of Michigan researchers have shown that glucose levels sustain the increased STAT3 activation in colorectal cancer cells. Their findings suggest that targeting glucose metabolism could inhibit STAT3, leading to novel therapeutic strategies.

The American Cancer Society reports that mortality rates have continued to decline since the 1990s. N. Lynn Henry, of Michigan Medicine, answers questions about how factors such as healthy lifestyle choices, early screening and clinical trials have improved cancer survival rates.

ALOX15 loss, which is common in colorectal tumors, impairs the cancer-preventative effects of fish oil. Read the full article on Health Lab.

Noninvasive colon cancer screening options have increased; new research looks at patient and physician preferences and impact of full follow-up colonoscopy insurance coverage.

Michigan Medicine study emphasizes the need to screen for the presence of ALOX15 in cancer patients when developing prevention strategies using fish oil supplements.

What to know about an at-home colorectal cancer screening test versus a colonoscopy.

An article discusses causes of early-onset cancer and ways to reduce your risk.

The #HOPE4LIVER trials, testing the safety efficacy of histotripsy as a treatment for primary and metastatic liver tumors, met its goals for technical success and safety. An expert explains more about it in this article.

Free colonoscopies for people whose at-home stool tests (such as Cologuard and FIT) turn up signs of potential cancer are now covered by insurance, and a study shows this will save money.

Study reveals presenting adults between 76 and 85 with personalized information about the benefits and harms of colon cancer screening decreases excess screening

Research finds genetic testing for cancer can bring more knowledge to patients and their relatives, but not many people get it done.